Samar Farha

1.7k total citations
38 papers, 1.1k citations indexed

About

Samar Farha is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Samar Farha has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 12 papers in Cardiology and Cardiovascular Medicine and 8 papers in Genetics. Recurrent topics in Samar Farha's work include Pulmonary Hypertension Research and Treatments (26 papers), Cardiovascular Function and Risk Factors (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Samar Farha is often cited by papers focused on Pulmonary Hypertension Research and Treatments (26 papers), Cardiovascular Function and Risk Factors (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Samar Farha collaborates with scholars based in United States, India and China. Samar Farha's co-authors include Serpil C. Erzurum, W.H. Wilson Tang, Margaret Park, Jacqueline Sharp, Kewal Asosingh, Suzy Comhair, Deepa George, James E. Loyd, James D. Thomas and Daniel Laskowski and has published in prestigious journals such as Circulation, Blood and PLoS ONE.

In The Last Decade

Samar Farha

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samar Farha United States 18 786 434 184 128 120 38 1.1k
C. Q. Deng United States 21 854 1.1× 241 0.6× 92 0.5× 74 0.6× 245 2.0× 53 2.2k
Kurt W. Prins United States 23 873 1.1× 804 1.9× 468 2.5× 121 0.9× 116 1.0× 63 1.6k
Étienne-Marie Jutant France 10 486 0.6× 216 0.5× 115 0.6× 54 0.4× 92 0.8× 46 828
Carmelita Marcantoni Italy 16 291 0.4× 380 0.9× 269 1.5× 67 0.5× 68 0.6× 29 1.3k
Debby Ngo United States 15 223 0.3× 244 0.6× 294 1.6× 119 0.9× 138 1.1× 27 904
Richard Vinisko United States 15 307 0.4× 230 0.5× 161 0.9× 368 2.9× 97 0.8× 36 1.2k
Monique E. Cho United States 12 165 0.2× 223 0.5× 262 1.4× 72 0.6× 132 1.1× 24 1.0k
Ana García‐Álvarez Spain 25 763 1.0× 1.4k 3.1× 211 1.1× 259 2.0× 68 0.6× 100 2.0k
Achim Obergfell Switzerland 19 219 0.3× 542 1.2× 386 2.1× 108 0.8× 88 0.7× 40 1.8k
A. Peacock United Kingdom 13 1.1k 1.4× 661 1.5× 68 0.4× 107 0.8× 101 0.8× 28 1.3k

Countries citing papers authored by Samar Farha

Since Specialization
Citations

This map shows the geographic impact of Samar Farha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar Farha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar Farha more than expected).

Fields of papers citing papers by Samar Farha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samar Farha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar Farha. The network helps show where Samar Farha may publish in the future.

Co-authorship network of co-authors of Samar Farha

This figure shows the co-authorship network connecting the top 25 collaborators of Samar Farha. A scholar is included among the top collaborators of Samar Farha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samar Farha. Samar Farha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Martens, Pieter, Brett Larive, Barry A. Borlaug, et al.. (2023). Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications. European Heart Journal. 44(22). 1979–1991. 17 indexed citations
4.
Farha, Samar, et al.. (2023). Hematopoietic stem cells and extramedullary hematopoiesis in the lungs. Cytometry Part A. 103(12). 967–977. 2 indexed citations
5.
Zhou, Yadi, Yuan Hou, Jiayu Shen, et al.. (2020). A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19. PLoS Biology. 18(11). e3000970–e3000970. 132 indexed citations
6.
Zoumot, Zaid, Ali S. Wahla, & Samar Farha. (2019). Rapidly progressive pleural effusion. Cleveland Clinic Journal of Medicine. 86(1). 21–27. 4 indexed citations
7.
Farha, Samar, Margaret Park, James D. Thomas, et al.. (2018). Endothelial Phenotype Evoked by Low Dose Carvedilol in Pulmonary Hypertension. Frontiers in Cardiovascular Medicine. 5. 180–180. 3 indexed citations
8.
Farha, Samar, Didem Saygın, Margaret Park, et al.. (2017). Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trial. JCI Insight. 2(16). 62 indexed citations
9.
Farha, Samar, Raed A. Dweik, Franck Rahaghi, et al.. (2014). Imatinib in Pulmonary Arterial Hypertension: C‐Kit Inhibition. Pulmonary Circulation. 4(3). 452–455. 30 indexed citations
10.
Ha, Duc, Jessica L. Mester, Charis Eng, & Samar Farha. (2014). Pulmonary Arterial Hypertension in a Patient with Cowden Syndrome and the PTEN Mutation. Pulmonary Circulation. 4(4). 728–731. 4 indexed citations
11.
Sharp, Jacqueline, Samar Farha, Margaret Park, et al.. (2014). Coenzyme Q supplementation in pulmonary arterial hypertension. Redox Biology. 2. 884–891. 31 indexed citations
12.
Farha, Samar, et al.. (2013). Bone Marrow–Derived Vascular Modulatory Cells in Pulmonary Arterial Hypertension. Pulmonary Circulation. 3(4). 781–791. 8 indexed citations
13.
Heresi, Gustavo A., Omar A. Minai, Adriano R. Tonelli, et al.. (2013). Clinical Characterization and Survival of Patients with Borderline Elevation in Pulmonary Artery Pressure. Pulmonary Circulation. 3(4). 916–925. 41 indexed citations
14.
Farha, Samar, Daniel Laskowski, Deepa George, et al.. (2013). Loss of alveolar membrane diffusing capacity and pulmonary capillary blood volume in pulmonary arterial hypertension. Respiratory Research. 14(1). 6–6. 40 indexed citations
15.
Farha, Samar, et al.. (2012). Novel Therapeutic Approaches to Preserve the Right Ventricle. Current Heart Failure Reports. 10(1). 12–17. 15 indexed citations
16.
Farha, Samar, Jacqueline Sharp, Kewal Asosingh, et al.. (2012). Mast Cell Number, Phenotype, and Function in Human Pulmonary Arterial Hypertension. Pulmonary Circulation. 2(2). 220–228. 57 indexed citations
17.
Farha, Samar, Kewal Asosingh, Weiling Xu, et al.. (2011). Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities. Blood. 117(13). 3485–3493. 107 indexed citations
18.
Ghosh, Sudakshina, Suzy Comhair, Samar Farha, et al.. (2011). High Levels of Zinc-Protoporphyrin Identify Iron Metabolic Abnormalities in Pulmonary Arterial Hypertension. Clinical and Translational Science. 4(4). 253–258. 21 indexed citations
19.
Farha, Samar, Kewal Asosingh, Daniel Laskowski, et al.. (2009). Effects of the Menstrual Cycle on Lung Function Variables in Women with Asthma. American Journal of Respiratory and Critical Care Medicine. 180(4). 304–310. 80 indexed citations
20.
Farha, Samar, et al.. (2006). Use of Noninvasive Positive-Pressure Ventilation on the Regular Hospital Ward: Experience and Correlates of Success. Respiratory Care. 51(11). 1237–1243. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Q. Deng Breakdown of academic impact, for papers by Kurt W. Prins Breakdown of academic impact, for papers by Étienne-Marie Jutant Breakdown of academic impact, for papers by Carmelita Marcantoni Breakdown of academic impact, for papers by Debby Ngo Breakdown of academic impact, for papers by Richard Vinisko Breakdown of academic impact, for papers by Monique E. Cho Breakdown of academic impact, for papers by Ana García‐Álvarez Breakdown of academic impact, for papers by Achim Obergfell Breakdown of academic impact, for papers by A. Peacock
Rankless by CCL
2026